Tacrolimus (Watson Laboratories, Inc.)
Welcome to the PulseAid listing for the Tacrolimus drug offered from Watson Laboratories, Inc.. This Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Watson Laboratories, Inc. |
| NON-PROPRIETARY NAME: | Tacrolimus |
| SUBSTANCE NAME: | TACROLIMUS |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Calcineurin Inhibitor Immunosuppressant [EPC],Calcineurin Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2010-07-06 |
| END MARKETING DATE: | 0000-00-00 |
Tacrolimus HUMAN PRESCRIPTION DRUG Details:
| Item Description | Tacrolimus from Watson Laboratories, Inc. |
| LABELER NAME: | Watson Laboratories, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 5(mg/1) |
| START MARKETING DATE: | 2010-07-06 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0591-3359_846c2bca-eedc-48d6-91e6-0cf871f32509 |
| PRODUCT NDC: | 0591-3359 |
| APPLICATION NUMBER: | ANDA090402 |
Other TACROLIMUS Pharmaceutical Manufacturers / Labelers:
